Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (241-250 of 306) with videos related to

Pageof 31
Sort By:
AIDS (London, England)|December 12, 2025
Disability pension and sick leave in people with HIV compared with the background population - a nationwide population-based matched cohort studyLars H Omland, Alban Senn, Anne Zutavern, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adultsEdwin DeJesus, Gisela Herrera, Eugenio Teofilo, et al.
AIDS (London, England)|June 10, 2014
Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapyHans J Hartling, Lise W Thørner, Christian Erikstrup, et al.
Antiviral Therapy|February 22, 2007
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trialZoe Fox, Ulrik B Dragsted, Jan Gerstoft, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2018
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysisTarik Asselah, Hendrik Reesink, Jan Gerstoft, et al.
AIDS (London, England)|September 16, 2015
Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analoguesAndrea Antinori, Amanda Clarke, Veronika Svedhem-Johansson, et al.
The American Journal of Tropical Medicine and Hygiene|September 12, 2008
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasisChristian Erikstrup, Per Kallestrup, Rutendo B L Zinyama-Gutsire, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Viruses|February 26, 2025
Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort StudyMoises Alberto Suarez-Zdunek, Andreas Dehlbæk Knudsen, Andreas Fuchs, et al.
The Lancet Regional Health. Europe|July 5, 2024
Survival among people with HIV and their families in Denmark 1995-2021: a nationwide population-based cohort studyCaroline Eves, Lars Haukali Omland, Jan Gerstoft, et al.
Pageof 31

Showing results (241-250 of 306) with videos related to

Sort By:
Pageof 31
AIDS (London, England)|December 12, 2025
Disability pension and sick leave in people with HIV compared with the background population - a nationwide population-based matched cohort studyLars H Omland, Alban Senn, Anne Zutavern, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adultsEdwin DeJesus, Gisela Herrera, Eugenio Teofilo, et al.
AIDS (London, England)|June 10, 2014
Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapyHans J Hartling, Lise W Thørner, Christian Erikstrup, et al.
Antiviral Therapy|February 22, 2007
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trialZoe Fox, Ulrik B Dragsted, Jan Gerstoft, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2018
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysisTarik Asselah, Hendrik Reesink, Jan Gerstoft, et al.
AIDS (London, England)|September 16, 2015
Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analoguesAndrea Antinori, Amanda Clarke, Veronika Svedhem-Johansson, et al.
The American Journal of Tropical Medicine and Hygiene|September 12, 2008
Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasisChristian Erikstrup, Per Kallestrup, Rutendo B L Zinyama-Gutsire, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Viruses|February 26, 2025
Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort StudyMoises Alberto Suarez-Zdunek, Andreas Dehlbæk Knudsen, Andreas Fuchs, et al.
The Lancet Regional Health. Europe|July 5, 2024
Survival among people with HIV and their families in Denmark 1995-2021: a nationwide population-based cohort studyCaroline Eves, Lars Haukali Omland, Jan Gerstoft, et al.
Pageof 31